EyePoint Pharmaceuticals Inc. (PV3B)
Market Closed
17 Jul, 20:00
XFRA 
€
11. 00
-1.1
-9.0909%
€
- Market Cap
- P/E Ratio
- Div Yield
250 Volume
-1.94 Eps
€ 12.1
Previous Close Want to track PV3B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PV3B Earnings Reports FAQ
What is the earnings per share (EPS) for PV3B?
The current EPS is -1.94.
What is the company's earnings growth rate?
EyePoint Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
EyePoint Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for EyePoint Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PV3B at this time, as EyePoint Pharmaceuticals Inc has no recent EPS data to calculate it.
